Emicizumab Prophylaxis for the Treatment of Infants with Severe Haemophilia A without Factor VIII Inhibitors: Primary Analysis of the HAVEN 7 Study

GTH Congress 2024 – 68th Annual Meeting of the Society of Thrombosis and Haemostasis Research – Building Bridges in Coagulation Pub Date : 2024-02-01 DOI:10.1055/s-0044-1779133

J. Oldenburg, S. Pipe, P. Collins, C. Dhalluin, G. Kenet, C. Schmitt, M. Buri, V. Jimenez-Yuste, F. Peyvandi, G. Young, M. E. Mancuso, K. Kavakli, A. Kiialainen, M. Niggli, T. Chang, M. Lehle, K. Fijnvandraat

引用次数: 0

查看原文本刊更多论文

埃米珠单抗预防性治疗无因子 VIII 抑制剂的重度血友病 A 婴儿：HAVEN 7研究的初步分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

GTH Congress 2024 – 68th Annual Meeting of the Society of Thrombosis and Haemostasis Research – Building Bridges in Coagulation

自引率

0.00%

发文量